Technology Venture Partners is a private equity general partner firm headquartered in Minneapolis, MN, United States.
Provider of bioanalytical instrumentation company RedShift BioAnalytics has closed a $11m Series C round from Waters Corporation and others.
Ultra-rapid Point-Of-Care molecular diagnostics company Atlas Genetics has raised $35m in Series D from Novartis Venture Funds and others.
Micrima, a breast imaging company and developer of a radiowave breast imaging system, has raised £2.6m in financing.
Read more news concerning Technology Venture Partners
A sampling of Technology Venture Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?